Heidi Chen

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations

Medicine, Genetics, Oncology +17

Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo et al. · Journal of Clinical Investigation · 2010 · 545 citations

Life Sciences, Molecular Biology, Oncology +17

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia et al. · Journal of Thoracic Oncology · 2015 · 430 citations · Full text

Medicine, Genetics, Oncology +16

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen et al. · Nature Medicine · 2014 · 267 citations · Full text

Medicine, Molecular Medicine, Oncology +12

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr et al. · Journal of Clinical Oncology · 2013 · 223 citations

Medicine, Oncology, Surgery +17